Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration

Mykola Prodanchuk, Oleksii Makarov, Evegnii Pisarev, Boris Sheiman, Mykola Kulyzkiy, Mykola Prodanchuk, Oleksii Makarov, Evegnii Pisarev, Boris Sheiman, Mykola Kulyzkiy

Abstract

Introduction: Accumulation of trace elements occurs in conditions of decreased kidney function. In some conditions, increased trace elements can have toxic features. On the other hand, studies are showing that concentration of some trace elements could be decreased in ERSD patients as well. The most important factor affecting trace element concentration in ERSD patients is the degree of renal failure and the usage of replacement therapy.

Materials and methods: We analyzed the trace elements' (boron, aluminum, vanadium, chromium, manganese, cobalt, nickel, copper, zinc, arsenic, selenium, rubidium, strontium, cadmium, cesium, barium and lead) concentration in the whole blood of 41 ESRD patients who were treated with hemodialysis and hemodiafiltration and also of 61 healthy blood donors. In addition, comparison of trace element blood levels of patients receiving hemodialysis and hemofiltration was carried out. Whole blood trace element concentration was determined using inductive coupled plasma mass-spectrometry (ICPMS).

Results: Levels of boron, aluminum, vanadium, chromium, manganese, zinc, strontium, cadmium, barium and lead were significantly increased in ESRD patients. Significantly decreased levels were observed for nickel, arsenic, selenium and rubidium. Blood levels of cobalt, copper, cadmium and lead in hemodialysis patients were significantly higher compared to patients receiving hemodiafiltration.

Conclusions: ESRD is accompanied with serious and multidirectional changes of trace element blood levels. The highest degree of blood level increases were observed for nonessential and toxic trace elements. Disorders of essential trace elements were manifested in a minor degree. Besides this, there were observed differences of trace element concentrations between ESRD patients receiving hemodialysis and hemo-diafiltration.

Keywords: end stage renal disease; hemodiafiltration; hemodyalisis; trace elements.

References

    1. Vanholder R, Cornelis R, Dhondt A, Lameire N. The role of trace elements in uraemic toxicity. Nephrol Dial Transplant. 2002;(Suppl 2):2–8.
    1. Miura Y, Nakai K, Suwabe A, Sera K. Trace elements in renal disease and hemodialysis. Nuclear instruments and methods in physics research. 2002;189:443–449.
    1. Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int. 1978;14:522–552.
    1. Zima T, Tesar V, Mestek O, Nemecek K. Trace elements in end-stage renal disease. Clinical implication of trace elements. Blood Purif. 1999;17:187–198.
    1. D'Haese PC, De Broe ME. Adequacy of dialysis: trace elements in dialysis fluids. Nephrol Dial Transplant. 1996;11(Suppl 2):92–97.
    1. Mactier R, Hoenich N, Breem C. Renal Association Clinical Practice Guideline on haemodialysis. Nephron Clin Pract. 2011;118(Suppl 1):c241–286.
    1. Obierlic D, Charland B, Skalnyi A. Biologic role of macro- and microelements in humans and animals; Sankt-Petersburg, Nauka; 2008. p. 542. [rus.]
    1. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, et al. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Medicine. 2009;7:25.
    1. Marumo F, Tsukfmoto Y, Iwanami S, Kishimoto T, Yamagami S. Trace elements concentrations in hair, fingernails and plasma of patients with chronic renal failure on hemodialysis and hemofiltration. Nephron. 1984;38:267–272.
    1. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron. 1991;57:10–15.
    1. Thomson N, Stevens B, Humphery T, Atkins R. Comparsion of trace elements in peritoneal dialysis, hemodialysis and uremia. Kidney Int. 1983;23:9–14.
    1. Mathieu D, Mathieu-Nolf M, Germain-Alonso M, Neviere R, Furon D, Wattel F. Massive arsenic poisoning-effect of hemodialysis and dimercaprol on arsenic kinetics. Intensive Care Med. 1992;18:47–50.
    1. Allain P, Mauras Y, Tafforeau C, Houssin A, Cartier F. Changes in the plasma and erythrocyte concentrations of rubidium in patients with renal failure. Presse Med. 1984;13:2249–2251.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit